Literature DB >> 34675666

Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study.

Godfrey Wekha1, Nelson Ssewante1, Angelique Iradukunda1, Micheal Jurua1, Shadia Nalwoga1, Sharon Lanyero1, Ronald Olum1, Felix Bongomin2,3.   

Abstract

INTRODUCTION: Colorectal cancer (CRC) is the most common type of gastrointestinal malignancies and the third leading cause of cancer-related deaths for both sexes worldwide. Although the burden of CRC is highest in developed countries, reports are indicating a rise in the incidence of early-onset CRC in developing countries. In this study, we aimed to determine the prevalence of CRC among patients hospitalized with lower gastrointestinal complaints at a tertiary health facility in Uganda.
METHODS: We conducted a 10-year retrospective chart review of patients admitted to Mulago National Referral Hospital in Kampala, Uganda, between 1st January 2010 and 31st December 2020. We reviewed all charts of patients admitted to the lower gastrointestinal tract (GIT) ward. Charts with grossly missing data, pediatric patients, and those from other non-lower GIT specialties were excluded.
RESULTS: Data of 1476 unique eligible patients were analyzed. Of these,138 had a diagnosis of CRC (prevalence: 9.3%, 95% confidence interval (95% CI): 6.5-11.7%). Among patients with CRC, the female:male ratio was 1:1. The most common site for CRC was the rectum (59.8%, n= 79). For the 138 participants with CRC, 44 had staging data with 72.8% (n=32) having advanced disease, that is, stage 3 or 4. Factors independently associated with CRC were age ≥50 years (adjusted odds ratio (aOR): 4.3, 95% CI: 2.6-7.1, p < 0.001), female sex (aOR: 1.8, 95% CI: 1.2 -2.8, p = 0.005), being widowed (aOR: 2.5, 95% CI: 1.3-5.0, p = 0.006), and presence of any risk factor for CRC (aOR: 5.3, 95% CI: 2.9-9.9, p < 0.001).
CONCLUSION: CRC is relatively common among patients hospitalized with lower GIT complaints, particularly among women and those with known risk factors for CRC. Awareness creation and screening programs should be instituted to allow early diagnosis of CRC in our setting.
© 2021 Wekha et al.

Entities:  

Keywords:  GIT malignancy; colon; colorectal cancer; rectum

Year:  2021        PMID: 34675666      PMCID: PMC8504868          DOI: 10.2147/CMAR.S334226

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


Introduction

Colorectal cancer (CRC) is one of the most common malignancies worldwide, third in men and second in women in terms of incidence, and the third leading cause of cancer-related deaths in both sexes.1 Globally, an estimated 10 million deaths occurred in 2020 due to cancers with CRC accounting for 9.4% of these deaths.2 In low- and middle-income countries (LMICs), it accounts for over 600,000 deaths annually, but data concerning cancer rates in these countries are generally very poor.3 CRC is currently considered to be one of the clearest markers of epidemiological and dietary change.4 The rise in the global burden is not uniform with significant variations influenced by geographic location, socio-economic status, age, and gender. Although high-income countries currently bear the heaviest burden, increasing civilization and dietary changes in LMICs, predict a threatening rise in the incidence rate of CRC.5 Indeed, the mortality rate due to rectum and colon cancers in LMICs is projected to rise by up to 60% and 71.5% respectively by 2035.5 Recent studies have underpinned a high body mass index (BMI), old age, family history of cancer, smoking, and frequent alcohol intake as risk factors for the development of CRC6,7 as do occupational exposures and physical inactivity.6,8–11 Over the past two decades, focused research to elucidate the genetic defects and molecular abnormalities associated with colorectal adenomas and carcinomas has been conducted to upscale screening programs.12–15 This has yielded promising results with many CRC cases now diagnosed before the onset of symptoms, especially in high-income countries. Knowledge of the pathobiology and risk factors has also proved useful in the identification of high-risk individuals an important aspect of CRC prevention programs.16,17 Unfortunately, in many LMICs including Uganda, few studies have been conducted to gather this information, and screening programs are yet to be conceptualized. Patients usually present with advanced disease with altered bowel habits, weight loss, anemia, abdominal discomfort, and rectal bleeding or diarrhea which predict a poor prognosis.3 While communicable diseases are still the major cause of death in Uganda, non-communicable diseases (NCDs) including CRC are on a rise. With the reported increase in the trend of CRC among young adults and adolescents in other parts of the world,18–20 Uganda needs to be equally concerned. Therefore, this study was conducted to provide a baseline trend of CRC in Uganda and shed light on the socio-demographic characteristics of those at risk so that interventions to reduce population risk and individual susceptibility can be formulated.

Methods

Study Design and Site

We conducted a retrospective chart review (RCR) at Mulago National Referral Hospital (MNRH) records Department from May to July 2021. Mulago is the main national referral hospital located in Kampala, Uganda. Before 2014, it was operating as a single unit serving Kampala metropolitan area, Wakiso and Mukono, and referrals from all the Regional Referral Hospitals. In 2014, Obstetrics and Gynecology department was relocated to now Kawempe National Referral Hospital, and the Department of Medicine was relocated to now Kiruddu National Referral Hospital with MNRH retaining Surgery and Pediatrics.

Study Population and Selection Criteria

Charts of all patients who were admitted to the lower gastrointestinal tract (GIT) ward from 1st January 2010 to 31st December 2020 were retrieved from archives and subjected to a rigorous selection and review process. Charts of pediatric patients, Specialties other than non-lower GIT specialties (ie, urology, orthopedics, and neurosurgery), and those with grossly missing data including sex, age, residence, marital status, occupation, and diagnosis were excluded.

Sampling Procedure

At MNRH, a paper-based record management system is still in practice. Patients’ charts are assigned the archive’s code based on their in-patient admission number. The latter is assigned on admission and therefore is based on the year of admission rather than the department where the patient is treated from. Since there’s no electronic database in place to trace all admitted patients, charts were manually retrieved from the archives. All files archived within the study period were reviewed.

Data Collection

Charts that met the selection criteria were isolated and information extracted using an electronic questionnaire designed with the Epicollect5 system. Sociodemographic data included age, sex, residence, marital status, religion, education level, occupation, and risk assessment including alcohol consumption, smoking, diet, and family history of malignancies and familial adenomatous polyposis (FAP) syndrome. However, due to missing data, some of these variables were dropped during pre-testing.

Data Management and Analysis

Completed questionnaires were downloaded from Epicollect5 and imported to Microsoft Excel 2016 for cleaning and coding. Cleaned data was exported to STATA V15 for analysis. Numerical data were summarized as means and standard deviations or median and interquartile range (IQR) as appropriate. Categorical data were summarized as frequencies and proportions. Associations between independent and dependent variables were assessed using chi-square or Fisher’s exact tests for categorical data and independent sample t-test or Mann–Whitney U-tests for numerical data. A p˂0.05 was considered statistically significant.

Ethical Considerations

The study was approved by Mulago Hospital Research and Ethics Committee (MHREC) under reference number MHREC: 2031. We chose MHREC instead of Makerere University School of Medicine Research and Ethics Committee corresponding to our affiliation because Makerere University College of Health sciences (MakCHS) uses MNRH as its teaching hospital and because the study was going to be conducted at MNRH. MHREC provided a waiver of consent since our study involved data collected from routine care. However, patients’ identifiers like names and inpatient numbers were excluded to ensure anonymity. This study was conducted in accordance with the principles outlined in the Declaration of Helsinki.

Results

Patient Demographic Characteristics

A total of 2252 patient charts were reviewed. Of these, 776 were excluded due to grossly missing data, and those belonging to other specialties; Figure 1. Finally, data of 1476 unique patients was analyzed.
Figure 1

Study flow diagram. 

Study flow diagram. Of the 1,476,979 (66.3%) were male and the overall median age was 38 (IQR: 13–92) years as shown in Figure 2. Majority, 1196 (81.6%) were from urban areas mainly from Kampala. Figure 3 shows the distribution of CRC cases across all districts in Uganda. Other characteristics are as summarized in Table 1.
Figure 2

Comparison of median age between CRC and Non-CRC patients.

Figure 3

Map of Uganda showing distribution of CRC cases.

Table 1

Patient Socio-Demographic Characteristics

VariablesAllCRC: n (%)Non-CRC: n (%)p-value
Overall1476138(9.3)1338(90.7)
Age; median (range)38 (IQR:13–92)58(IQR:16–85)36(IQR: 13–87)<0.001
Age groups<0.001
 <501000(67.8)42(4.2)958(95.8)
 ≥50476(32.2)96(20.2)380(79.8)
Sex<0.001
 Female497(33.7)70(14.1)427(85.9)
 Male979(66.3)68(6.9)911(93.1)
Tribes0.573
 Bantu1220(82.7)112(9.2)1108(90.8)
 Nilotes176(11.9)20(11.4)156(88.6)
 Others80(5.4)6(7.5)74(92.5)
Residence (n=1466)0.002
 Rural270(18.4)39(14.4)231(85.6)
 Urban1196(81.6)98(8.2)1098(91.8)
Marital status (n=1219)<0.001
 Married728(59.7)77(10.6)651(89.4)
 Separated20(1.6)2(10)18(90)
 Single420(34.5)17(4)403(96)
 Widowed51(4.2)20(39.2)31(60.8)
Occupation (n=405)0.243
 Skilled92(22.7)6(6.5)86(93.5)
 Unemployed10(2.5)2(20)8(80)
 Unskilled303(74.8)29(9.6)274(90.4)
Risk factors<0.001
 No1401(94.9)114(8.1)1287(91.9)
 Yes75(5.1)24(32)51(68)
Patient Socio-Demographic Characteristics Comparison of median age between CRC and Non-CRC patients. Map of Uganda showing distribution of CRC cases. Seventy-five (5.1%) participants had risk factors for CRC recorded. This included alcohol consumption, smoking, diet on red meat, HIV, and family history of malignancies as shown in Figure 4.
Figure 4

Risk factors associated with CRC.

Risk factors associated with CRC.

Prevalence of CRC

The period prevalence of CRC was found to be 9.3%. The lowest prevalence, 5.5% (4/73) was recorded in 2015 while the highest, 18.8% (21/112) was recorded in 2019. The trend of CRC cases in relation to the charts reviewed from 2010 to 2020 is represented in Figure 5.
Figure 5

The trend of CRC cases recorded from 2010 to 2020.

The trend of CRC cases recorded from 2010 to 2020.

Factors Associated with CRC

At bivariate analysis, age (p < 0.001), sex (p < 0.001), marital status (p < 0.001), residence (p = 0.002), and presence of any risk factor for CRC (p < 0.001) were significantly associated with a diagnosis of CRC as indicated in Table 1. However, in the multivariate analysis, Table 2, residence was found not to be statistically significant (p = 0.603). However, age, sex, marital status, and the presence of any risk factor for CRC including alcohol, smoking, HIV, family history of malignancy, and diet maintained statistical significance. The odds of having CRC was 4.3-fold higher in participants aged 50 years and above compared to those younger than 50 years (aOR: 4.3, 95% CI: 1.2–7.1, p < 0.001). Female were found to have 1.8-fold higher odds of developing CRC compared to men (aOR: 1.8, 95% CI: 1.2–2.8, p < 0.001). Patients who were widowed had 2.5-fold higher odds of having CRC compared to their married counterparts (aOR: 2.5, 95% CI: 1.3–5.0, p = 0.006) while those identified to have at least one risk factor for CRC had a 5.3-fold higher odds of having CRC compared to those who had none (aOR: 5.3, 95% CI: 2.9–9.9, p < 0.001).
Table 2

Multivariate Logistic Regression of Factors Associated with Colorectal Cancer

VariablesAdjusted Odds Ratiop-value95% Confidence Interval
Age group
 <50Reference
 ≥504.3<0.0012.6–7.1
Sex
 MaleReference
 Female1.80.0051.2–2.8
Residence
 RuralReference
 Urban0.90.6030.5–1.4
Marital Status
 MarriedReference
 Single0.80.4120.4–1.4
 Separated1.80.4620.4–8.2
 Widowed2.50.0061.3–5.0
Any risk factor *
 NoReference
 Yes5.3<0.0012.9–9.9

Note: *Risk factors included alcohol consumption, smoking, diet, and family history of malignancies.

Multivariate Logistic Regression of Factors Associated with Colorectal Cancer Note: *Risk factors included alcohol consumption, smoking, diet, and family history of malignancies.

Clinical Characteristics of CRC at MNRH

Table 3 summarizes clinical features of the CRC cases recorded in the years 2010 to 2020.
Table 3

Clinical Characteristics of CRC at MNRH

VariablesFrequencyPercentage
Site of CRC lesion (n= 132)
 Rectum7959.8
 Colon4735.6
 Rectosigmoid64.5
Staging (n= 44)
 IIA511.4
 IIIA12.3
 IIIB1022.7
 IIIC511.4
 IVB1636.4
 NX24.5
 Unclassifieda511.4
Histology (n= 36)
 Well differentiated adenocarcinoma719.4
 Moderately differentiated adenocarcinoma822.2
 Poorly differentiated adenocarcinoma38.3
 Squamous carcinoma25.6
 Villous adenocarcinoma12.8
 Papillary carcinoma12.8
 Unclassified a1438.9

Note: aCommented on the characteristic of the tumor but neither staging nor histology done.

Clinical Characteristics of CRC at MNRH Note: aCommented on the characteristic of the tumor but neither staging nor histology done.

Discussion

CRC is a major public health problem whose etiopathology is not well understood. Globally, CRC is reported to be on the rise with new cases occurring in LMICs where infections have traditionally been a major concern. CRC is the third most common cancer in both males and females worldwide with an estimated 1.9 million new cases in 2020 alone.1,21 It is also the second most prevalent cancer and the second leading cause of cancer deaths.1 Recent reports predict that the global cancer burden will reach 28.4 million cases by 2040, with most cases (64–95%) occurring in developing countries.1 Risk factors for this disproportionately high burden are partly due to the aging population and partly to the rapid globalization and the adoption of the associated risk factors within these populations.7,22,23 Because of the lack of priority-setting systems in these countries, an epidemic of communicable and non-communicable diseases is likely to emerge.24,25 In this study, we found a high prevalence of CRC at 9.3% across all age groups among patients admitted to the lower GIT ward of MNRH Kampala. This is rather a higher disease burden compared to that previously reported by Bukirwa et al where the disease incidence was found at 4.1%.26 This difference in the statistics could be explained by the lack of nationwide screening programs and diagnostic capacities in regional referral hospitals. However, this seems to be a general problem for all LMICs where gaps in detection potentials are reflected in low incidences of CRCs and other cancers. A recent report from GLOBOCAN shows that much as there’s a global increase in CRC cases, Africa still has the lowest prevalence accounting for only 3.4% of the total 1.93 Million new cases regardless of it being the second most populated continent.1 Our study showed that age, sex, marital status, and presence of at least one known risk factor for CRC were strongly associated with CRC. In this study, the likelihood of having CRC was increasing with advancing age, and people above 50 years were at an increased risk. This is in agreement with most literature that conventionally identifies advanced age as a risk factor for CRC.27–29 However, up to 30.4% of CRC cases in this study were diagnosed before 50 years of age. Similar findings were noted in studies conducted in the US, Kenya, Eritrea, and Zambia.30–33 What’s noteworthy is the fact that these patients present with advanced disease and factors that drive this rapid progression are yet to be understood. Patients in this age group had no history of alcohol consumption, cigarette smoking, comorbidity, or family history of cancer. Indeed, recent reports have also noted rising cases of CRC among adolescents and young adults (AYAs),34–37 and the most commonly involved sites were the distal colon and rectum.35,38 Unfortunately, the factors influencing this rise are yet to be determined. Genetic predisposition in the face of increasingly sedentary lifestyles as evidence by a steep rise in other NCDs is a possible explanation.28,32 Therefore, urgent research is needed to demonstrate the role of screening, illustrate the pathobiology of the disease in these age groups, and explore treatment options for optimal care. Contrary to current knowledge,28,29 females were found to have a greater risk of developing CRC compared to their male counterparts in the current study. Better health-seeking behaviors exhibited by females in Uganda could explain this finding.39 Related studies have used difference in life expectancy among males and females as an explanation for gender disparity.40,41 Remarkably, marital status was found to be associated with CRC in our study. Widowed patients were 2.5 times more likely to have CRC compared to married patients. To the best of our knowledge, there was no literature supporting this finding. However, this could be explained by the fact that widowed patients do not have regulatory attempts of spouses to monitor their health and promote healthy behavior. And because they do not have anyone to feel responsible towards or get emotional support, they are less likely to engage in healthy lifestyle behaviors.42,43 Risk factors for CRC assessed in this study included alcohol consumption, smoking, low fiber and high animal protein diet, family history of malignancies, HIV, and FAP. As expected, patients who had any of these risk factors were more likely to have been diagnosed with CRC. In the study, only 5.1% of the charts reviewed had documented risks for CRC. However, there was no quantification of the amount of alcohol consumed or pack-years for those who smoked. To date, documentation is still a problem, especially in developing countries. As a consequence, this leads to inaccurate statistical data, poor patients care, and financial losses,44 and missed opportunities for those with hereditary predisposition who would otherwise benefit from prevention measures. This finding correlates with that of a study conducted by Abernethy et al, where only 64 of 499 charts of eligible CRC patients were included in the final analysis because of missing data.45 The role of diet in the development of CRC has been studied in depth. Most recent studies implicate a diet high in fat, especially saturated fatty acids, red meat, and low in fiber, vitamin D, or dairy products.46 The risk of development of CRC due to a high-fat diet is thought to be due to exposure of gut mucosa to carcinogenic heterocyclic amines, polycyclic aromatic hydrocarbons,47 and nitroso compounds.48,49 Unlike the current study that did not find a strong relationship between diet and CRC, two previous studies demonstrated a significant relationship between plasma phospholipids and CRC.50,51 As previously mentioned, poor documentation could have contributed to this negative finding. Over the past decade, CRC has been on the rise globally with an overall incidence of 29 per 100,000 in men and 20 per 100,000 in women.1 In this study, however, there seemed to be two peaks between 2010 and 2012 and 2018 and 2020, respectively. Age-adjusted statistics also follow the same trend with all age groups affected equally. Consistent with previous reports, we found no statistically significant difference in tumor location in both sexes.52 However, the most common sites were the rectum and cecum with most patients (72.8%) having advanced disease which is in agreement with a study conducted in Zambia and South Africa.33 This finding could be a result of poor health service-seeking behavior in the general population, lack of risk stratification models for CRC, and the fact that the disease is asymptomatic until its advanced stage. CRC is a heterogeneous disease at the molecular and genetic levels. The vast majority of cases result from polyps (slow-growing precursors) that can easily be cured by simple resection. Widely accepted mechanisms of development of CRC include the Chromosomal instability (CIN) pathway accounting for more than 80% of cases,53 CpG island methylation phenotype (CIMP) that leads to the development of sporadic CRC,54 and the pure microsatellite instability pathway. Our study is the first empirical study in Uganda to attempt to determine the prevalence and factors associated with CRC. However, the results of this research should be construed with caution due to some limitations. Firstly, some of the patients’ charts had a great deal of missing data hence they were excluded from the study and secondly, the filing system at the records office entailed the use of admission numbers as opposed to the specialty or ward of admission thus fewer patients’ charts were reviewed in comparison to that in the sample size. Secondly, the catchment area of the study site is limited to majorly central Uganda and thus findings may not be generalizable to the entire country. Future prospective cohort studies could be conducted to identify the population at risk and incidence of CRC. Particularly, clinicians should seek to screen patients with identifiable risk factors for CRC so that appropriate interventions are performed timely.

Conclusions

There is a substantial burden of CRC among patients with lower GIT complaints in Uganda. Females are more affected than males with a median age of 50 years or more. There was no link between sex and the site of primary lesion as previously reported by literature in other parts of the world. Notably, we found a high incidence of CRC among AYAs. Due to a lack of screening programs, patients present with advanced CRC disease which is associated with a poor prognosis. Screening and risk stratification programs need to be introduced to improve clinical outcomes of CRC patients and to enable early identification of those at risk.
  48 in total

1.  Serum organochlorine pesticide levels in patients with colorectal cancer in Egypt.

Authors:  A S Soliman; M A Smith; S P Cooper; K Ismail; H Khaled; S Ismail; R S McPherson; I A Seifeldin; M L Bondy
Journal:  Arch Environ Health       Date:  1997 Nov-Dec

2.  Association of marital status and colorectal cancer screening participation in the USA.

Authors:  B El-Haddad; F Dong; K J Kallail; R B Hines; E Ablah
Journal:  Colorectal Dis       Date:  2015-05       Impact factor: 3.788

Review 3.  Incidence and Risk Factors of Colorectal Cancer in the Iranian Population: a Systematic Review.

Authors:  Hossein Mozafar Saadati; Batool Okhovat; Farzad Khodamoradi
Journal:  J Gastrointest Cancer       Date:  2021-01-04

4.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

Review 5.  Worldwide variations in colorectal cancer.

Authors:  Melissa M Center; Ahmedin Jemal; Robert A Smith; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2009 Nov-Dec       Impact factor: 508.702

Review 6.  Dietary Intake of Meat Cooking-Related Mutagens (HCAs) and Risk of Colorectal Adenoma and Cancer: A Systematic Review and Meta-Analysis.

Authors:  Manuela Chiavarini; Gaia Bertarelli; Liliana Minelli; Roberto Fabiani
Journal:  Nutrients       Date:  2017-05-18       Impact factor: 5.717

Review 7.  Prevalence and risk factors of colorectal cancer in Asia.

Authors:  Martin Cs Wong; Hanyue Ding; Jingxuan Wang; Paul Sf Chan; Junjie Huang
Journal:  Intest Res       Date:  2019-05-20

8.  Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age.

Authors:  Wesal H Abualkhair; Meijiao Zhou; Dennis Ahnen; Qingzhao Yu; Xiao-Cheng Wu; Jordan J Karlitz
Journal:  JAMA Netw Open       Date:  2020-01-03

9.  Cancer in Africa: The Untold Story.

Authors:  Yosr Hamdi; Ines Abdeljaoued-Tej; Afzal Ali Zatchi; Sonia Abdelhak; Samir Boubaker; Joel S Brown; Alia Benkahla
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

Review 10.  The CpG island methylator phenotype (CIMP) in colorectal cancer.

Authors:  Ehsan Nazemalhosseini Mojarad; Peter Jk Kuppen; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more
  2 in total

1.  High Expression of circ_0001821 Promoted Colorectal Cancer Progression Through miR-600/ISOC1 Axis.

Authors:  Cheng Li; Xudong Gao; Yi Zhao; Xin Chen
Journal:  Biochem Genet       Date:  2022-08-09       Impact factor: 2.220

2.  Risk Factors for Colorectal Adenocarcinoma in an Indigenous Population in East Africa.

Authors:  Richard Wismayer; Julius Kiwanuka; Henry Wabinga; Michael Odida
Journal:  Cancer Manag Res       Date:  2022-09-06       Impact factor: 3.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.